NEUP vs RHI · rev $15.7M vs P/E 21, rev $5.38B
Neuphoria Therapeutics Inc (NEUP) versus Robert Half International Inc (RHI) — a side-by-side from cached financials, not a winner call.
Neuphoria Therapeutics Inc (NEUP) is a biotechnology company listed on NASDAQ.
Robert Half International Inc (RHI) is a staffing & employment services company listed on US.
Latest reported NEUP revenue for 2025-03-31 was $15.7M. Net income was $8.5M. NEUP currently screens at market cap $23.6M.
Latest reported RHI revenue for 2025-12-31 was $5.38B. Net income was $133.0M. RHI currently screens at market cap $4.38B and trailing P/E 21.4.
NEUP currently screens at market cap $23.6M. RHI currently screens at market cap $4.38B and trailing P/E 21.4.
Not investment advice. Open the NEUP and RHI stock pages for the full models.
Not investment advice.